Iroko names Louis Vollmer president, CEO

PHILADELPHIA — Iroko Pharmaceuticals on Monday announced that it had named Louis Vollmer to the positions of president and CEO at the company, effective July 6. He has been president of the company since March 2015 and succeeds Iroko founder Osagie Imasogie as CEO. 

 

Vollmer will oversee day-to-day operations and long-term planning for Iroko, with a focus on its SoluMatrix franchise brands. Osagie will stay on as chairman of Iroko’s board. 

 

"Lou is a seasoned and well-respected leader whose perspective and business acumen will be invaluable to Iroko as it evolves into a true leader in providing responsible pain management options to healthcare professionals and patients," Imasogie said. 

 

Vollmer began his more than 25-year career in the pharmaceutical industry at DuPont Merck, eventually becoming SVP sales and marketing for DuPont Multi Source Products. He was also one of three founding partners and management team leaders of Endo Pharmaceuticals. 

 

“I am honored to lead Iroko at this stage of the company's evolution," Vollmer said. “Iroko is in a strong position for growth within the United States and worldwide. I look forward to helping the company deliver significant value to patients and healthcare professionals and achieving strong and sustainable growth.”